Anti-Mouse CD317 [Clone 927] — Purified in vivo PLATINUM™ Functional Grade
Anti-Mouse CD317 [Clone 927] — Purified in vivo PLATINUM™ Functional Grade
Product No.: C792
Clone 927 Target CD317 Formats AvailableView All Product Type Monoclonal Antibody Alternate Names BST2, tetherin, HM1.2 antigen, bone marrow stromal antigen 2, PDCA-1 Isotype Rat IgG2b κ Applications Depletion , FA , FC , ICC , IF Microscopy , in vivo |
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Rat Recommended Isotype Controls Recommended Dilution Buffer Immunogen Mouse plasmacytoid dendritic cells Product Concentration ≥ 5.0 mg/ml Endotoxin Level <0.5 EU/mg as determined by the LAL method Purity ≥98% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Pathogen Testing To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM™ antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day 2-8°C Applications and Recommended Usage? Quality Tested by Leinco FC Additional Applications Reported In Literature ? In vivo depletion immunofluorescence microscopy functional assay Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone 927 activity is directed against murine CD317 (BST2; PDCA-1). Background Monoclonal antibody (mAb) 927 recognizes CD317 (BST2; PDCA-1)1. CD317 is a specific marker of IFN-producing cells (IPCs aka plasmacytoid dendritic cells, DC) under naïve conditions. IPCs are early responders to viral infection and direct both the innate and adaptive immune response2,3. CD317 also promotes secretion in IPCs, presumably by sorting proteins between the Golgi apparatus and plasma membrane1. CD317 is located on the cell surface as well as intracellularly in the Golgi apparatus and is associated with lipid rafts.
CD317 is primarily present on the cell surfaces of murine IPCs in naïve mice, where its expression on resting and activated IPCs is independent of IFNs1. However, when stimulated with type I IFNs and IFN-γ, cell surface expression of CD317 is induced on most cell types. When administered in vivo, treatment with mAb 927 abrogates IFN-α secretion by IPCs in response to CpG as well as depletes IPCs ~ 95%, significantly reducing plasma cells. The 927 clone was generated to overcome barriers to the identification and study of IPCs caused by their scarcity in blood and tissues as well as their complex surface phenotype1. mAb 927 was generated by immunizing Wistar/CRL rats with bone marrow-derived IPCs with either CpG oligodeoxynucleotide 1826 or heat-killed Mycobacteria tuberculosis as adjuvant. Hybridoma lines were created by fusing popliteal lymph nodes with SP2/0 myeloma cells. Supernatants were screened for lines that recognize CD11c+B220+Ly-6c+CD11b-splenocytes. mAb 927 is rat IgG2b isotype. Antigen Distribution Murine CD317 is expressed by IFN-producing cells in naïve mouse spleen and by a wide variety of cell lines including T cells, mast cells, B cells, fibroblast cells, and pluripotent embryonal carcinoma cells. Additionally, mice challenged by influenza or other stimuli (CpG, LPS, murine CMV, poly(I:C), and imiquimod) express CD317 in DC and other myeloid cells as well as T cells, B cells, NKT cells, and some NK cells. CD317 is also expressed on CD138+ plasma cells in naïve mice and is upregulated by viral stimulation. Function Recently identified antiviral protein that blocks the release of nascent retrovirus or other particles from infected cells. NCBI Gene Bank ID UniProt.org Research Area Immunology Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Clone 927 is a monoclonal antibody commonly used in in vivo mouse studies to specifically deplete plasmacytoid dendritic cells (pDCs) and to block interferon-alpha (IFN-?) secretion by pDCs and other IFN-producing cells. Its target is murine CD317 (also known as BST2 or PDCA-1), a cell surface molecule predominantly expressed on these cell types. Key uses and details:
In summary, in vivo mouse studies use clone 927 to deplete pDCs and block type I interferon production, enabling mechanistic studies of immune cell function, especially relating to the innate response to pathogens and immunomodulation. The correct storage temperature for sterile packaged clone 927 (anti-mouse CD317 monoclonal antibody) is 2–8°C when stored as received in sterile form for up to one month. For longer-term storage, aliquot the product aseptically without diluting and store at ? –70°C. Avoid repeated freeze-thaw cycles to preserve antibody integrity.
These guidelines apply specifically to sterile, functional-grade clone 927 antibody, as per the manufacturer's recommendations. For any changes in storage or handling practices, consult the lot-specific datasheet, as they may be periodically updated. Some of the most commonly used antibodies or proteins with clone 927 in the literature include surface markers and lineage-defining proteins typical of immune and dendritic cell profiling, as well as markers for specific cell depletion and functional assays. Key antibodies or proteins that are often used in combination with 927 include:
In the generation and validation of clone 927, hybridomas were screened against cells that were CD11c^+ B220^+ Ly-6C^+ CD11b^? (splenocytes) to ensure specificity for murine CD317/BST2 (PDCA-1), which is the antigen recognized by 927. In addition, 927 itself is commonly used for:
These antibody combinations and panels are widely reported in the immunology literature to characterize or experimentally deplete pDC populations and to study immune responses in various mouse models. Key findings from scientific literature that cite "clone 927" primarily relate to its use as a monoclonal antibody targeting mouse CD317 (also known as BST2 or PDCA-1) and to its utility in the identification, depletion, and functional study of interferon-producing cells (IPCs), especially plasmacytoid dendritic cells (pDCs). Key Findings:
Broader Implications:
Alternative "927" Usage:
In summary, clone 927 citations in scientific papers consistently highlight its pivotal role as a tool for identifying, depleting, and functionally analyzing mouse IPCs/pDCs, thus facilitating research in immunology and cell biology. References & Citations1. Blasius AL, Giurisato E, Cella M, et al. J Immunol. 177(5):3260-3265. 2006.
2. Colonna M, Trinchieri G, Liu YJ. Nat Immunol. 5(12):1219-1226. 2004. 3. Liu YJ. Annu Rev Immunol. 23:275-306. 2005. 4. Yun TJ, Lee JS, Machmach K, et al. Cell Metab. 23(5):852-866. 2016. 5. Toivonen R, Kong L, Rasool O, et al. J Immunol. 196(11):4750-4759. 2016. 6. Moniz RJ, Chan AM, Gordon LK, et al. FEMS Immunol Med Microbiol. 58(3):397-404. 2010. 7. Rajagopal D, Paturel C, Morel Y, et al. Blood. 115(10):1949-1957. 2010. 8. Nash WT, Gillespie AL, Brown MG. Front Immunol. 8:251. 2017. 9. Bradley KC, Finsterbusch K, Schnepf D, et al. Cell Rep. 28(1):245-256.e4. 2019. 10. Schliemann C, Roesli C, Kamada H, et al. Blood. 115(3):736-744. 2010. Technical ProtocolsCertificate of Analysis |
Formats Available
Prod No. | Description |
---|---|
C791 | |
C799 | |
C785 | |
C786 | |
C783 | |
C784 | |
C792 | |
P420 |
